Verity Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Verity Asset Management's MDT Position: Q2 2026 in Review
Verity Asset Management reduced its Medtronic (MDT) stake by 23% in Q2 2026, selling an estimated $78.7K and leaving 3,278 shares worth $256K. The position accounts for 0.1% of the portfolio, ranked #202.
Verity Asset Management first reported a position in MDT in Q4 2013 and has held it in 22 quarters since. The position peaked at $1.12M in Q1 2015. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Verity Asset Management held 3,278 shares of Medtronic worth $256K as of Q2 2026.
- Verity Asset Management sold 976 Medtronic shares in Q2 2026, an estimated $78.7K.
- Medtronic made up 0.1% of Verity Asset Management's portfolio in Q2 2026, its #202 holding.
- Verity Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 22 quarters since.
- Verity Asset Management's Medtronic position peaked at $1.12M in Q1 2015.
- 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Verity Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.